Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure.
作者： Thomas M Seed , Vijay K. Singh
DOI: 10.3389/FPHAR.2021.624844
关键词: Drug development 、 Drug approval 、 Intensive care medicine 、 Acute Radiation Syndrome 、 Drug repositioning 、 Radiation exposure 、 Drug 、 Food and drug administration 、 Repurposing 、 Medicine
摘要: … of amifostine are being combined with other radiation countermeasures under development with the objective to increase the efficacy of amifostine … in combination with amifostine, and …
frontiersin.org
sci-hub.st 参考文章(211)
Thomas J. MacVittie, Ann M. Farese, Walter G. Smith, Charles M. Baum, Earl Burton, John P. McKearn, Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression. Blood. ,vol. 95, pp. 837- 845 ,(2000) , 10.1182/BLOOD.V95.3.837.003K08_837_845
K R Imrie, H M Prince, F Couture, A Keating, J M Brandwein, Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole. Bone Marrow Transplantation. ,vol. 15, pp. 267- 270 ,(1995)
BI Lord, G Molineux, Z Pojda, LM Souza, JJ Mermod, TM Dexter, Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo Blood. ,vol. 77, pp. 2154- 2159 ,(1991) , 10.1182/BLOOD.V77.10.2154.2154
N. Hunter, D. J. Grdina, Y. Kataoka, L. Milas, J. Perrin, Antimutagenic effects of amifostine: clinical implications. Seminars in Oncology. ,vol. 23, pp. 53- 57 ,(1996)
Adrian Covic, Ivo Abraham, State-of-the-art biosimilar erythropoietins in the management of renal anemia: lessons learned from Europe and implications for US nephrologists International Urology and Nephrology. ,vol. 47, pp. 1529- 1539 ,(2015) , 10.1007/S11255-015-1042-9
Frank Hawking, Diethylcarbamazine and new compounds for the treatment of filariasis. Advances in pharmacology. ,vol. 16, pp. 129- 194 ,(1979) , 10.1016/S1054-3589(08)60244-6
Tokuhisa Hirouchi, Koichi Ito, Manabu Nakano, Satoru Monzen, Hironori Yoshino, Mitsuru Chiba, Masaharu Hazawa, Akira Nakano, Junya Ishikawa, Masaru Yamaguchi, Kimio Tanaka, Ikuo Kashiwakura, Mitigative Effects of a Combination of Multiple Pharmaceutical Drugs on the Survival of Mice Exposed to Lethal Ionizing Radiation. Current Pharmaceutical Biotechnology. ,vol. 17, pp. 190- 199 ,(2015) , 10.2174/1389201016666150826125331
MEETHA MEDHORA, FENG GAO, ELIZABETH R. JACOBS, JOHN E. MOULDER, Radiation damage to the lung: Mitigation by angiotensin‐converting enzyme (ACE) inhibitors Respirology. ,vol. 17, pp. 66- 71 ,(2012) , 10.1111/J.1440-1843.2011.02092.X
T. M. Seed, T. E. Fritz, D. V. Tolle, C. M. Poole, L. S. Lombard, D. E. Doyle, L. V. Kaspar, S. M. Cullen, B. A. Carnes, Survival Patterns and Hemopathological Responses of Dogs Under Continuous Gamma Irradiation Response of Different Species to Total Body Irradiation. pp. 137- 159 ,(1984) , 10.1007/978-94-009-6048-0_9
Hiroaki Hemmi, Osamu Takeuchi, Taro Kawai, Tsuneyasu Kaisho, Shintaro Sato, Hideki Sanjo, Makoto Matsumoto, Katsuaki Hoshino, Hermann Wagner, Kiyoshi Takeda, Shizuo Akira, A Toll-like receptor recognizes bacterial DNA. Nature. ,vol. 408, pp. 740- 745 ,(2000) , 10.1038/35047123